Cart
sales@molnova.com
H-Gly-Arg-Ala-Asp-Ser-Pro-Lys-OH
CAS No. 125455-58-5
H-Gly-Arg-Ala-Asp-Ser-Pro-Lys-OH( ——— )
Catalog No. M39932 CAS No. 125455-58-5
H-Gly-Arg-Ala-Asp-Ser-Pro-Lys-OH
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameH-Gly-Arg-Ala-Asp-Ser-Pro-Lys-OH
-
NoteResearch use only, not for human use.
-
Brief DescriptionH-Gly-Arg-Ala-Asp-Ser-Pro-Lys-OH
-
DescriptionH-Gly-Arg-Ala-Asp-Ser-Pro-Lys-OH
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number125455-58-5
-
Formula Weight729.8
-
Molecular FormulaC29H51N11O11
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tertiapin LQ
Blocker of Kir1.1 channels; displays >250-fold selectivity for Kir1.1 (Kd values are 1.1, 274 and 361 nM for Kir1.1, Kir3.1/3.2 and Kir3.1/3.4 respectively). Derivative of tertiapin-Q.
-
GDP366
GDP366, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells. a dual inhibitor of survivin and Op18.
-
BIM-46187 4HCl
PH-064 4HCl is a heterotrimeric G-protein complex inhibitor.
